Gunilla Nordin Fredrikson (Former)
76 – 90 of 125
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
FCGAMMARIIB Inhibits The Development Of Atherosclerosis In Mice
(
- Contribution to journal › Published meeting abstract
-
Mark
Evidence Of A Role Of T Regulatory Cells Mediating Atheroprotection By APO B 100 Peptide Immunization
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.885-885(
- Contribution to journal › Published meeting abstract
-
Mark
Associations Between Human Leukocyte Antigen (HLA) Genotype And Acute Myocardial Infarction
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.953-953(
- Contribution to journal › Published meeting abstract
-
Mark
Apob-100 Peptide Immunization Reduce Macrophage Plaque Infiltration In Apobec1-/- Ldlr-/- Mice With Advanced Atherosclerotic Lesions
(
- Contribution to journal › Published meeting abstract
-
Mark
Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
(
- Contribution to journal › Article
-
Mark
Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.
(
- Contribution to journal › Article
-
Mark
Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
(
- Contribution to journal › Article
-
Mark
Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells.
(
- Contribution to journal › Article
- 2008
-
Mark
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men
(
- Contribution to journal › Article
-
Mark
Evaluation of the T cell response to apolipoprotein B100 (ApoB100): A new opportunity for immunotherapy against atherosclerosis
(
- Contribution to journal › Published meeting abstract
-
Mark
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction
(
- Contribution to journal › Article
-
Mark
Elastin- and Collagen-Rich Human Carotid Plaques Have Increased Levels of the Cysteine Protease Inhibitor Cystatin C.
(
- Contribution to journal › Article
-
Mark
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
(
- Contribution to journal › Article